Article Details
Retrieved on: 2021-12-21 13:28:22
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Adults with AChR antibodies treated for 26 weeks with Alexion's complement-blocking therapy showed significant gains in CHAMPION MG study.
Article found on: myastheniagravisnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here